These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11841044)

  • 1. Application of resampling techniques to estimate exact significance levels for covariate selection during nonlinear mixed effects model building: some inferences.
    Gobburu JV; Lawrence J
    Pharm Res; 2002 Jan; 19(1):92-8. PubMed ID: 11841044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of actual significance levels for covariate effects in NONMEM.
    Wählby U; Jonsson EN; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2001 Jun; 28(3):231-52. PubMed ID: 11468939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covariate detection in population pharmacokinetics using partially linear mixed effects models.
    Bonate PL
    Pharm Res; 2005 Apr; 22(4):541-9. PubMed ID: 15846461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast method for testing covariates in population PK/PD Models.
    Khandelwal A; Harling K; Jonsson EN; Hooker AC; Karlsson MO
    AAPS J; 2011 Sep; 13(3):464-72. PubMed ID: 21725709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of correlation on covariate selection in linear and nonlinear mixed effect models.
    Bonate PL
    Pharm Stat; 2017 Jan; 16(1):45-54. PubMed ID: 27580760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models.
    Haem E; Harling K; Ayatollahi SM; Zare N; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):55-66. PubMed ID: 28144841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of type I error rates for the statistical sub-model in NONMEM.
    Wählby U; Bouw MR; Jonsson EN; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):251-69. PubMed ID: 12449498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modified Hybrid Wald's Approximation Method for Efficient Covariate Selection in Population Pharmacokinetic Analysis.
    Zou Y; Tang F; Ng CM
    AAPS J; 2021 Mar; 23(2):37. PubMed ID: 33660056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and performance of a population pharmacokinetic model.
    Ette EI
    J Clin Pharmacol; 1997 Jun; 37(6):486-95. PubMed ID: 9208355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.
    Ribbing J; Nyberg J; Caster O; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2007 Aug; 34(4):485-517. PubMed ID: 17516152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covariate pharmacokinetic model building in oncology and its potential clinical relevance.
    Joerger M
    AAPS J; 2012 Mar; 14(1):119-32. PubMed ID: 22274748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM
    Sukarnjanaset W; Wattanavijitkul T; Jarurattanasirikul S
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):729-736. PubMed ID: 29785609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.
    Tunblad K; Lindbom L; McFadyen L; Jonsson EN; Marshall S; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2008 Oct; 35(5):503-26. PubMed ID: 19011957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient algorithms for covariate analysis with dynamic data using nonlinear mixed-effects model.
    Yuan M; Zhu Z; Yang Y; Zhao M; Sasser K; Hamadeh H; Pinheiro J; Xu XS
    Stat Methods Med Res; 2021 Jan; 30(1):233-243. PubMed ID: 32838650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test.
    Xu XS; Yuan M; Yang H; Feng Y; Xu J; Pinheiro J
    AAPS J; 2017 Jan; 19(1):264-273. PubMed ID: 27761720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
    Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):393-414. PubMed ID: 22767341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.
    Wählby U; Jonsson EN; Karlsson MO
    AAPS PharmSci; 2002; 4(4):E27. PubMed ID: 12645999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling.
    Dosne AG; Bergstrand M; Harling K; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):583-596. PubMed ID: 27730482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated covariate model building within NONMEM.
    Jonsson EN; Karlsson MO
    Pharm Res; 1998 Sep; 15(9):1463-8. PubMed ID: 9755901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.